134 related articles for article (PubMed ID: 14559795)
1. Polypyrimidine tract-binding protein down-regulates fibroblast growth factor receptor 1 alpha-exon inclusion.
Jin W; Bruno IG; Xie TX; Sanger LJ; Cote GJ
Cancer Res; 2003 Oct; 63(19):6154-7. PubMed ID: 14559795
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors.
Jin W; McCutcheon IE; Fuller GN; Huang ES; Cote GJ
Cancer Res; 2000 Mar; 60(5):1221-4. PubMed ID: 10728679
[TBL] [Abstract][Full Text] [Related]
3. An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein.
Carstens RP; Wagner EJ; Garcia-Blanco MA
Mol Cell Biol; 2000 Oct; 20(19):7388-400. PubMed ID: 10982855
[TBL] [Abstract][Full Text] [Related]
4. Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements.
Bruno IG; Jin W; Cote GJ
Hum Mol Genet; 2004 Oct; 13(20):2409-20. PubMed ID: 15333583
[TBL] [Abstract][Full Text] [Related]
5. CELF and PTB proteins modulate the inclusion of the β-tropomyosin exon 6B during myogenic differentiation.
Sureau A; Saulière J; Expert-Bezançon A; Marie J
Exp Cell Res; 2011 Jan; 317(1):94-106. PubMed ID: 20875406
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma cell-specific expression of fibroblast growth factor receptor-1beta requires an intronic repressor of RNA splicing.
Jin W; Bi W; Huang ES; Cote GJ
Cancer Res; 1999 Jan; 59(2):316-9. PubMed ID: 9927039
[TBL] [Abstract][Full Text] [Related]
7. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
Ashiya M; Grabowski PJ
RNA; 1997 Sep; 3(9):996-1015. PubMed ID: 9292499
[TBL] [Abstract][Full Text] [Related]
8. Cloning and expression of fibroblast growth factor receptor-1 isoforms in the mouse heart: evidence for isoform switching during heart development.
Jin Y; Pasumarthi KB; Bock ME; Lytras A; Kardami E; Cattini PA
J Mol Cell Cardiol; 1994 Nov; 26(11):1449-59. PubMed ID: 7897669
[TBL] [Abstract][Full Text] [Related]
9. Polypyrimidine tract-binding protein represses splicing of a fibroblast growth factor receptor-2 gene alternative exon through exon sequences.
Le Guiner C; Plet A; Galiana D; Gesnel MC; Del Gatto-Konczak F; Breathnach R
J Biol Chem; 2001 Nov; 276(47):43677-87. PubMed ID: 11557769
[TBL] [Abstract][Full Text] [Related]
10. Enhancer-dependent splicing of FGFR1 alpha-exon is repressed by RNA interference-mediated down-regulation of SRp55.
Jin W; Cote GJ
Cancer Res; 2004 Dec; 64(24):8901-5. PubMed ID: 15604250
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing of neurexins: a role for neuronal polypyrimidine tract binding protein.
Resnick M; Segall A; G GR; Lupowitz Z; Zisapel N
Neurosci Lett; 2008 Jul; 439(3):235-40. PubMed ID: 18534753
[TBL] [Abstract][Full Text] [Related]
12. Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain.
McCutcheon IE; Hentschel SJ; Fuller GN; Jin W; Cote GJ
Neuro Oncol; 2004 Jan; 6(1):9-14. PubMed ID: 14769134
[TBL] [Abstract][Full Text] [Related]
13. Suppression of glioblastoma cell growth following antisense oligonucleotide-mediated inhibition of fibroblast growth factor receptor expression.
Yamada SM; Yamaguchi F; Brown R; Berger MS; Morrison RS
Glia; 1999 Oct; 28(1):66-76. PubMed ID: 10498824
[TBL] [Abstract][Full Text] [Related]
14. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
Hovhannisyan RH; Carstens RP
Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847
[TBL] [Abstract][Full Text] [Related]
15. Antisense-mediated exon skipping to shift alternative splicing to treat cancer.
Wan J
Methods Mol Biol; 2012; 867():201-8. PubMed ID: 22454063
[TBL] [Abstract][Full Text] [Related]
16. RNAi-mediated PTB depletion leads to enhanced exon definition.
Wagner EJ; Garcia-Blanco MA
Mol Cell; 2002 Oct; 10(4):943-9. PubMed ID: 12419237
[TBL] [Abstract][Full Text] [Related]
17. Terminal antisense oligonucleotide modifications can enhance induced exon skipping.
Gebski BL; Errington SJ; Johnsen RD; Fletcher S; Wilton SD
Neuromuscul Disord; 2005 Oct; 15(9-10):622-9. PubMed ID: 16084084
[TBL] [Abstract][Full Text] [Related]
18. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development.
Ladd AN; Stenberg MG; Swanson MS; Cooper TA
Dev Dyn; 2005 Jul; 233(3):783-93. PubMed ID: 15830352
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.
Smith PY; Delay C; Girard J; Papon MA; Planel E; Sergeant N; Buée L; Hébert SS
Hum Mol Genet; 2011 Oct; 20(20):4016-24. PubMed ID: 21807765
[TBL] [Abstract][Full Text] [Related]
20. Suggestive evidence on the involvement of polypyrimidine-tract binding protein in regulating alternative splicing of MAP/microtubule affinity-regulating kinase 4 in glioma.
Fontana L; Rovina D; Novielli C; Maffioli E; Tedeschi G; Magnani I; Larizza L
Cancer Lett; 2015 Apr; 359(1):87-96. PubMed ID: 25578778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
